CSL Limited
CSL
1991 – June 1994
Previously Commonwealth Serum Laboratories Commission (1961–1991).
Wholly Commonwealth-owned public company that carried on the Commonwealth Serum Laboratories' business of manufacturing vaccines, plasma products and other biologicals.
Names over time
- Commonwealth Serum Laboratories1916–1961
- Commonwealth Serum Laboratories Commission1961–1991
- CSL Limited1991–1994
How it came into existence
Formed in 1991 by converting the Commonwealth Serum Laboratories Commission into a public company limited by shares under the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990, with the Commonwealth as sole shareholder.
- Vaccine and biological product manufacture
- Blood plasma fractionation
Converted into a public company
Legislation: Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990
How it ended
Privatised in June 1994, when the Keating Government sold its shares in a public float and CSL Limited was listed on the Australian Stock Exchange.
Main functions
- Manufacture of vaccines
- Fractionation of blood plasma for the national blood supply
- Production of antivenoms and other biologicals
- Commercial sale of pharmaceutical and veterinary products
Where it sits
Last in the portfolio of Department of Human Services and Health.
Lineage
Loading lineage…
Sources
Other sources
Some dates or links for this organisation are not fully confirmed. Corrections are welcome.